| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.095 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |